Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sertraline 100mg tablets
0403030Q0AAABAB
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 1,356,027 |
|
Sertraline 50mg tablets
0403030Q0AAAAAA
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 1,293,903 |
|
Sertraline 25mg tablets
0403030Q0AAAZAZ
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 77,665 |
|
Sertraline 150mg tablets
0403030Q0AABABA
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 13,772 |
|
Sertraline 200mg tablets
0403030Q0AABBBB
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 8,856 |
|
Sertraline 50mg/5ml oral suspension
0403030Q0AAAQAQ
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 2,610 |
|
Sertraline 100mg/5ml concentrate for oral soln sugar free
0403030Q0AABCBC
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 2,195 |
|
Sertraline 50mg/5ml oral suspension sugar free
0403030Q0AABDBD
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 761 |
|
Sertraline 100mg/5ml oral suspension
0403030Q0AAARAR
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 693 |
|
Sertraline 25mg/5ml oral suspension
0403030Q0AAAXAX
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 284 |
|
Sertraline 150mg/5ml oral suspension
0403030Q0AAAKAK
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 9 |
|
Sertraline 50mg/5ml oral solution
0403030Q0AAAVAV
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 4 |
|
Sertraline 25mg/5ml oral solution
0403030Q0AAAWAW
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 1 |
|
Sertraline 10mg/5ml oral suspension
0403030Q0AAAPAP
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | No data available |
|
Sertraline 12.5mg tablets
0403030Q0AAAYAY
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | No data available |
|
Sertraline 12.5mg/5ml oral suspension
0403030Q0AAAIAI
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | No data available |
|
Sertraline 15mg/5ml oral suspension
0403030Q0AAASAS
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | No data available |
|
Sertraline 20mg/5ml oral suspension
0403030Q0AAANAN
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | No data available |
|
Sertraline 5mg/5ml oral suspension
0403030Q0AAATAT
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | No data available |
|
Sertraline 75mg/5ml oral suspension
0403030Q0AAAUAU
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.